MB-CART20.1 Melanoma

Clinical trial NCT03893019 · TERMINATED

Trial details

NCT number: NCT03893019
Sponsor: Miltenyi Biomedicine GmbH
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2019-03-08
Primary completion: 2023-01-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.